The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
Open accessAbstract
BACKGROUND: In patients with locoregional carcinoma of the esophagus or esophagogastric junction who underwent preoperative chemoradiation, it is unclear whether survival was better predicted by pretherapy clinical stage or by posttherapy pathologic stage. METHODS: The authors studied 235 consecutive patients with pretherapy clinical Stage II, III, or IVA (according to American Joint Committee on Cancer criteria) carcinoma of the esophagus or esophagogastric junction who were treated with chemoradiation followed by esophagectomy. Posttherapy cancer status was classified using pathologic stage and semiquantitative assessment of residual carcinoma. Clinicopathologic features, residual carcinoma status, and pretherapy and posttherapy stage were compared with disease‐free and overall survival. RESULTS: Posttherapy pathologic stage was Stage 0 in 29% of patients, Stage I in 11% of patients, Stage II in 34% of patients, Stage III in 20% of patients, and Stage IV in 6% of patients. Cancer downstaging occurred in 56% of patients. In univariate analysis, disease‐free and overall survival were predicted by posttherapy pathologic stage (both with P < 0.001), margin status (P = 0.002 and P = 0.01, respectively), extent of residual carcinoma (both with P < 0.001), and downstaging (both with P = 0.001), but not by age, gender, type of cancer, pretherapy clinical stage, or preoperative regimen. However, in multivariate analysis, disease‐free and overall survival were independently predicted by posttherapy pathologic stage (both with P = 0.02). Extent of residual carcinoma was a marginally significant predictor of overall survival (P = 0.04). CONCLUSIONS: Posttherapy pathologic stage was the best available predictor of outcome for patients with locoregional carcinoma of the esophagus or esophagogastric junction who underwent chemoradiation therapy followed by esophagectomy. The findings in the current study supported the concept of downstaging by preoperative therapy. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,509
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
Mandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
Walsh, T. N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., & Hennessy, T. P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350702 · Cited by 1,950
Hulscher, J. B. F., van Sandick, J. W., de Boer, A. G. E. M., Wijnhoven, B. P. L., Tijssen, J. G. P., Fockens, P., Stalmeier, P. F. M., ten Kate, F. J. W., van Dekken, H., Obertop, H., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022343 · Cited by 1,629
(2002) · The Lancet · doi:10.1016/s0140-6736(02)08651-8 · Cited by 1,459
Bosset, J.-F., Gignoux, M., Triboulet, J.-P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J.-C., Pavy, J.-J., Mercier, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370304 · Cited by 1,376
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Self-citationUrba, S. G., Orringer, M. B., Turrisi, A., Iannettoni, M., Forastiere, A., & Strawderman, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.305 · Cited by 1,266
Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus
Akiyama, H., Tsurumaru, M., Udagawa, H., & Kajiyama, Y. (1994) · Annals of Surgery · doi:10.1097/00000658-199409000-00012 · Cited by 901
Webb, A., Cunningham, D., Scarffe, J. H., Harper, P., Norman, A., Joffe, J. K., Hughes, M., Mansi, J., Findlay, M., Hill, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.261 · Cited by 870
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
Becker, K., Mueller, J. D., Schulmacher, C., Ott, K., Fink, U., Busch, R., Böttcher, K., Siewert, J. R., & Höfler, H. (2003) · Cancer · doi:10.1002/cncr.11660 · Cited by 827
AJCC Cancer Staging Manual, 6th edition
Schmoll, H.-J. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg077 · Cited by 729
Weber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Prise, E. L., Etienne, P. L., Meunier, B., Maddern, G., Hassel, M. B., Gedouin, D., Boutin, D., Campion, J. P., & Launois, B. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1779::aid-cncr2820730702>3.0.co;2-t · Cited by 617
Nygaard, K., Hagen, S., Hansen, H. S., Hatlevoll, R., Hultborn, R., Jakobsen, A., Mäntyla, M., Modig, H., Munck‐Wikland, E., Rosengren, B., et al. (1992) · World Journal of Surgery · doi:10.1007/bf02067069 · Cited by 615
Flamen, P., Lerut, A., Van Cutsem, E., De Wever, W., Peeters, M., Stroobants, S., Dupont, P., Bormans, G., Hiele, M., De Leyn, P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3202 · Cited by 571
Ando, N., Ozawa, S., Kitagawa, Y., Shinozawa, Y., & Kitajima, M. (2000) · Annals of Surgery · doi:10.1097/00000658-200008000-00013 · Cited by 540
Forastiere, A. A., Orringer, M. B., Perez-Tamayo, C., Urba, S. G., & Zahurak, M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1118 · Cited by 366
Curative Resection for Esophageal Adenocarcinoma: Analysis Of 100 En Bloc Esophagectomies
Hagen, J. A., DeMeester, S. R., Peters, J. H., Chandrasoma, P., & DeMeester, T. R. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00011 · Cited by 351
Webb, A., Cunningham, D., Cotter, F., Ross, P., Walters, J., Judson, I., Raynaud, F., Clarke, P., & Dziewanowska, Z. E. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)86090-x · Cited by 321
Surgical Strategies in Esophageal Carcinoma With Emphasis on Radical Lymphadenectomy
LERUT, T., LEYN, P. D., COOSEMANS, W., RAEMDONCK, D. V., SCHEYS, I., & LESAFFRE, E. (1992) · Annals of Surgery · doi:10.1097/00000658-199211000-00010 · Cited by 311
Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography
Block, M. I., Patterson, G. A., Sundaresan, R. S., Bailey, M. S., Flanagan, F. L., Dehdashti, F., Siegel, B. A., & Cooper, J. D. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00619-x · Cited by 259
Preoperative chemotherapy for resectable thoracic esophageal cancer
Kidane, B., Coughlin, S., Vogt, K., & Malthaner, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001556.pub3 · Cited by 237
Leichman, L., Steiger, Z., Seydel, H. G., Dindogru, A., Kinzie, J. L., Toben, S., MacKenzie, G., & Shell, J. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.2.75 · Cited by 229
Proposed Revision Of The Staging Classification For Esophageal Cancer
Korst, R. J., Rusch, V. W., Venkatraman, E., Bains, M. S., Burt, M. E., Downey, R. J., & Ginsberg, R. J. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70332-0 · Cited by 219
Law, S., Kwong, D. L. W., Kwok, K.-F., Wong, K.-H., Chu, K.-M., Sham, J. S. T., & Wong, J. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000086545.45918.ee · Cited by 160
Coia, L. R., Minsky, B. D., Berkey, B. A., John, M. J., Haller, D. G., Landry, J. C., Pisansky, T. M., Willett, C. G., Hoffman, J. P., Owen, J. B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.455 · Cited by 147
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson, D. H., Forastiere, A. A., Arquette, M. A., Costa, F., Heelan, R. T., Huang, Y., & Kelsen, D. P. (2000) · PubMed · Cited by 135
Rohatgi, P. R., Swisher, S. G., Correa, A. M., Wu, T., Liao, Z. X., Komaki, R. R., Walsh, G. L., Vaporciyan, A. A., Rice, D. C., Roth, J. A., et al. (2005) · Cancer · doi:10.1002/cncr.21439 · Cited by 134
Self-citationHeath, E. I., Burtness, B. A., Heitmiller, R. F., Salem, R. R., Kleinberg, L. R., Knisely, J. P. S., Yang, S. C., Talamini, M. A., Kaufman, H. S., Canto, M. I., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.868 · Cited by 132
Self-citationWong, R. K. S., Malthaner, R. A., Zuraw, L., & Rumble, R. B. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04278-5 · Cited by 76
Ajani, J. A., Walsh, G. L., Komaki, R. R., Morris, J., Swisher, S. G., Putnam, J. B., Lynch, P. M., Wu, T., Smythe, R. W., Vaporciyan, A. A., et al. (2004) · Cancer · doi:10.1002/cncr.20284 · Cited by 68
Self-citationKleinberg, L. R., Knisely, J. P. S., Heitmiller, R. F., Zahurak, M., Salem, R. R., Burtness, B. A., Heath, E., & Forastiere, A. A. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04598-4 · Cited by 65
Preoperative chemotherapy for resectable thoracic esophageal cancer
Malthaner, R. A., & Fenlon, D. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001556 · Cited by 65
van Westreenen, H. L., Heeren, P. A. M., Jager, P. L., van Dullemen, H. M., Groen, H., & Plukker, J. T. M. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.005 · Cited by 55
Darnton, S. J., Archer, V. R., Stocken, D. D., Mulholland, P. J., Casson, A. G., & Ferry, D. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.236 · Cited by 51
Cited by
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112088 · Cited by 5,521
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Farjah, F., Gerdes, H., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0019 · Cited by 569
Self-citationEschrich, S. A., Pramana, J., Zhang, H., Zhao, H., Boulware, D., Lee, J.-H., Bloom, G., Rocha-Lima, C., Kelley, S., Calvin, D. P., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.014 · Cited by 360
Esophageal and Esophagogastric Junction Cancers
Ajani, J. A., Barthel, J. S., Bentrem, D. J., D'Amico, T. A., Das, P., Denlinger, C. S., Fuchs, C. S., Gerdes, H., Glasgow, R. E., Hayman, J. A., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0072 · Cited by 331
Self-citationLiu, J., Yang, Y., Liu, Z., Fu, X., Cai, X., Li, H., Zhu, L., Shen, Y., Zhang, H., Sun, Y., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004291 · Cited by 282
Metadata
- Authors
- Chirieac, L. R., Swisher, S. G., Ajani, J. A., Komaki, R. R., Correa, A. M., Morris, J. S., Roth, J. A., Rashid, A., Hamilton, S. R., & Wu, T.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-02-17
- Volume
- 103
- Issue
- 7
- Pages
- 1347-1355
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2054305985
- Cited by
- 495
- References
- 39
- FWCI
- 17.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.